SOLEXA

solexa-logo

Solexa engages in developing and commercializing genetic analysis technologies primarily in the United States and the United Kingdom. The company is developing and preparing Solexa Genome Analysis System, which performs DNA sequencing based on its proprietary reversible terminator Sequencing-by-Synthesis, chemistry, and Clonal Single Molecule Array technology. Its platform is designed to support a range of analyses, including whole genome resequencing, gene expression analysis, and small RNA analysis.

#SimilarOrganizations #People #Financial #More

SOLEXA

Industry:
Biotechnology Genetics Medical Medical Device

Founded:
1998-01-01

Address:
Hayward, California, United States

Country:
United States

Total Employee:
101+

Status:
Active

Total Funding:
222.9 M USD


Similar Organizations

illumina-logo

Illumina

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.

tarsa-therapeutics-logo

Tarsa Therapeutics

Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.


Current Advisors List

genghis-lloyd-harris_image

Genghis Lloyd-Harris Board of Directors @ Solexa
Board_member

joseph-e-whitters_image

Joseph E. Whitters Board Director @ Solexa
Board_member

Current Employees Featured

shankar-balasubramian_image

Shankar Balasubramian
Shankar Balasubramian Founder @ Solexa
Founder

david-klenerman_image

David Klenerman
David Klenerman Founder @ Solexa
Founder

garrison-morfit_image

Garrison Morfit
Garrison Morfit Former Director @ Solexa
Former Director

clive-g-brown_image

Clive G. Brown
Clive G. Brown Director of Computational Biology & IT @ Solexa
Director of Computational Biology & IT
2003-01-01

Founder


david-klenerman_image

David Klenerman

shankar-balasubramian_image

Shankar Balasubramian

Stock Details


Company's stock symbol is NASDAQ:SLXA

Investors List

azimuth-opportunity_image

Azimuth Opportunity

Azimuth Opportunity investment in Post-IPO Equity - Solexa

valueact-capital_image

ValueAct Capital

ValueAct Capital investment in Private Equity Round - Solexa

schroder-ventures_image

Schroder Ventures

Schroder Ventures investment in Series B - Solexa

amadeus-capital-partners_image

Amadeus Capital Partners

Amadeus Capital Partners investment in Series B - Solexa

oxford-bioscience-partners_image

Oxford Bioscience Partners

Oxford Bioscience Partners investment in Series B - Solexa

abingworth-management_image

Abingworth

Abingworth investment in Series B - Solexa

schroder-ventures_image

Schroder Ventures

Schroder Ventures investment in Series A - Solexa

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Venture Round - Solexa

More informations about "Solexa"

Solaxa Inc.

Solaxa is a clinical-stage biopharmaceutical company developing treatments for rare neurodegenerative disease and nerve injury. We are pursuing both novel and reformulated โ€ฆSee details»

Solexa 2025 Company Profile: Valuation, Investors, โ€ฆ

Solexa General Information Description. Developer of genetic analysis technologies designed for pharmaceutical, biotechnology, and agricultural โ€ฆSee details»

Home - Solexa Group

Solexa combines the talents of its principals to bring together a high level of experience in finance and management. The principals of Solexa have each been active in corporate and real estate finance for more than a decade. Contact โ€ฆSee details»

History of Illumina Sequencing & Solexa Technology

In 2001, the Solexa teamโ€™s research progress attracted £12 million in Series A funding, enabling it to build its management team. Three years later, Solexa acquired molecular clustering โ€ฆSee details»

Solexa - Products, Competitors, Financials, Employees, โ€ฆ

Solexa specializes in genetic analysis technologies within the biotechnology sector. Use the CB Insights Platform to explore Solexa's full profile. ... Genomics Inc., among others. โ€œWe are โ€ฆSee details»

10th anniversary story: Solexa โ€“ Cambridge Enterprise

Jun 1, 2016 Illumina acquires Solexa. In November 2006, Solexa was purchased by US-based company Illumina for $650 million. Since then, Illumina has used the technology as the foundation of its sequencing instruments, โ€ฆSee details»

Solexa Sequencing | Collaboration and Impact - Yusuf โ€ฆ

Today Solexa next generation sequencing technology is at the heart of all of Illuminaโ€™s sequencing products. Solexa sequencing has made very large-scale projects possible, and Solexa-Illumina sequencers are the technology that โ€ฆSee details»

Solexa, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore Solexa, Inc. with its drug pipeline, therapeutic area, technology platform, 6 news, and 33 literature, Drug:KRX-211.See details»

Solexa: second-gen genetic sequencing โ€“ Cambridge โ€ฆ

Jul 13, 2015 Solexa and its technology were acquired by Illumina in early 2007 for $650 million. Since that time Balasubramanian has remained a senior advisor to Illumina and in 2015 the technology can sequence a human genome for just โ€ฆSee details»

Solexa - VentureRadar

The CEO, John West, was formerly CEO of the leading DNA sequencing company, Solexa (a former Abingworth portfolio company). (08/11) VV Venture Valuation Switzerland Privately โ€ฆSee details»

How We Pioneered Next Generation DNA Sequencing At Solexa โ€“ II

Apr 28, 2025 The Solexa team at Chesterford Research Park circa 2003. Chesterford Research Park, once an insecticide research centre, had passed through the hands of various โ€ฆSee details»

Solexa - Funding, Financials, Valuation & Investors - Crunchbase

Solexa develops a genome analysis system for genome resequencing, gene expression analysis and small RNA analysis. ... Experience the new Crunchbase, powered by AI . Experience the โ€ฆSee details»

Video: Solexa Anniversary - Illumina

Feb 21, 2017 More than 200 employees joined in the celebration to mark the Solexa and Illumina success that created a truly global impact. The Solexa story started in August 1997 โ€ฆSee details»

Solexa - Updates, News, Events, Signals & Triggers - Crunchbase

Solexa develops a genome analysis system for genome resequencing, gene expression analysis and small RNA analysis.See details»

The Solexa Story - Bio-IT World

Sep 24, 2010 By March 2005, Solexa was a publicly traded company on NASDAQ. โ€œIt was a stroke of genius economically,โ€ said Swerdlow. โ€œLynx was worth $12 million, we were worth โ€ฆSee details»

Solexa - Contacts, Employees, Board Members, Advisors & Alumni

Organization. Solexa . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Solexa has 4 current employee profiles, including โ€ฆSee details»

41J Blog » Blog Archive » A Solexa Story

Jan 28, 2016 Solexa Announces Agreement for $65 Million Private Placement HAYWARD, Calif. and CAMBRIDGE, Englandโ€“(BUSINESS WIRE)โ€“Nov. 21, 2005โ€“Solexa, Inc. (Nasdaq:SLXA) โ€ฆSee details»

Sequencing-by-Synthesis: Explaining the Illumina Sequencing โ€ฆ

Feb 7, 2025 Illumina went on to purchase Solexa in 2007 and has built upon, and rapidly improved the original technology. Millions of reactions and the reversible terminators The โ€ฆSee details»

Solexa - Crunchbase

Solexa develops a genome analysis system for genome resequencing, gene expression analysis and small RNA analysis.See details»

linkstock.net © 2022. All rights reserved